Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Cash from Operations (2020 - 2025)

Caribou Biosciences has reported Cash from Operations over the past 6 years, most recently at 20792000.0 for Q4 2025.

  • Quarterly Cash from Operations rose 41.38% to 20792000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 110992000.0 through Dec 2025, up 19.69% year-over-year, with the annual reading at 110992000.0 for FY2025, 19.69% up from the prior year.
  • Cash from Operations was 20792000.0 for Q4 2025 at Caribou Biosciences, up from 25217000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 20313000.0 in Q1 2021 and troughed at 37203000.0 in Q1 2024.
  • The 5-year median for Cash from Operations is 23710000.0 (2022), against an average of 23298400.0.
  • Year-over-year, Cash from Operations plummeted 206.7% in 2022 and then soared 41.38% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 21389000.0 in 2021, then dropped by 17.09% to 25044000.0 in 2022, then increased by 14.63% to 21379000.0 in 2023, then plummeted by 65.91% to 35470000.0 in 2024, then soared by 41.38% to 20792000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Cash from Operations are 20792000.0 (Q4 2025), 25217000.0 (Q3 2025), and 28258000.0 (Q2 2025).